摘要: Several recent gene patent controversies have energized and refocused the human debate in Canada. These include use of Myriad test for breast cancer by provinces, patenting
sci-hub.se 参考文章(22)
Bartha Maria Knoppers, Timothy Caulfield, T. Douglas Kinsella, Book Reviews-Legal Rights and Human Genetic Material ,(1998)
Timothy Caulfield, Lorraine Sheremeta, R. Gold, Harmonizing commercialization and gene patent policy with other social goals ,(2003)
Wendy Armstrong, Michael Wynne, Building on Values: The Future of Health Care in Canada ,(2005)
Bryn Williams-Jones, History of a gene patent: tracing the development and application of commercial BRCA testing. Health law journal. ,vol. 10, pp. 123- 146 ,(2002)
R. M. Cook-Deegan, INTELLECTUAL PROPERTY: Patents, Secrecy, and DNA Science. ,vol. 293, pp. 217- 217 ,(2001) , 10.1126/SCIENCE.1058032
Brigitte van Beuzekom, Biotechnology Statistics in OECD Member Countries: An Inventory Research Papers in Economics. ,(2000) , 10.1787/168436240651
R. G. Worton, Legal Rights and Human Genetic Material. Canadian Medical Association Journal. ,vol. 157, pp. 447- 447 ,(1997)
M. R. Henry, GENETICS: DNA Patenting and Licensing Science. ,vol. 297, pp. 1279- 1279 ,(2002) , 10.1126/SCIENCE.1070899
Jerome H. Reichman, David L. Lange, Bargaining Around the TRIPS Agreement: The Case for Ongoing Public-Private Initiatives to Facilitate Worldwide Intellectual Property Transactions Duke Journal of Comparative and International Law. ,vol. 9, pp. 11- 68 ,(1998)
W. Kondro, Universities Promise More Tech Transfer Science. ,vol. 298, pp. 1699- 1701 ,(2002) , 10.1126/SCIENCE.298.5599.1699A